FDA Inspection 883252 — Taizhou Taifa Pharmaceuticals Co., Ltd.
The FDA completed an inspection of Taizhou Taifa Pharmaceuticals Co., Ltd. on May 15, 2014 in Xianju, Taizhou. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- May 15, 2014
- Fiscal Year
- 2014
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Xianju, Taizhou (China)